Luo Mary Z.
Officer at AMPH
- Sold, on record
- $33.9M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Jan 9, 2024
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AMPHAmphastar Pharmaceuticals, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AMPHPlan not statedDec 13, 2018 2018
Sold 133,915 shares at $21.29 ($2.9M)
Luo Mary Z., COO,Chief Scientist & Chairman
Sold 1.8% of holdings ($159M position)7.3M shares leftFirst sale on recordFiling
- 2 Form 4 sale AMPHPlan not statedSep 11, 2019 +272 days
Sold 300,000 shares at $20.82 ($6.2M)
Luo Mary Z., COO,Chief Scientist & Chairman
Sold 4.1% of holdings ($153M position)7M shares leftFiling
- 3 Form 4 sale AMPHPlan not statedMay 17, 2022 +979 days
Sold 118,445 shares at $35.75 ($4.2M)
Luo Mary Z., CEO & Chief Scientific Officer
Sold 5.1% of holdings ($83.7M position)2.2M shares leftFirst sale on recordFiling
- 4 Form 4 sale AMPHPlan not statedMay 19, 2022 +2 days
Sold 108,776 shares at $34.00 ($3.7M)
Luo Mary Z., CEO & Chief Scientific Officer
Sold 4.9% of holdings ($75.6M position)2.1M shares leftFiling
- 5 Form 144 notice AMPHNoticeJan 8, 2024 +599 days
Filed to sell 133,644 shares ($7.9M)
Luo Mary Z., Officer
10b5-1 planFiling
- 6 Form 144 notice AMPHNoticeJan 9, 2024 +1 day
Filed to sell 86,156 shares ($5.1M)
Luo Mary Z., Officer
10b5-1 planFiling
- 7 Form 4 sale AMPHRoutineJan 9, 2024 same day
Sold 219,800 shares at $58.23 ($12.8M)
Luo Mary Z., COO,Chief Scientist & Chairman
10b5-1 planSold 15.1% of holdings ($84.8M position)1.2M shares leftFollows a Form 144Filing
- 8 Form 144 notice AMPHNoticeJan 10, 2024 +1 day
Filed to sell 131,386 shares ($7.2M)
Luo Mary Z., Officer
10b5-1 plan1.1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | Jan 10, 2024 | AMPH | Officer | Form 144 notice | 131,386 | $7.2M | Notice | SEC | |
| Jan 9, 2024 | Jan 10, 2024 | AMPH | COO,Chief Scientist & Chairman | Form 4 sale | 219,800 | $12.8M | 15.1% | Routine | SEC |
| Jan 9, 2024 | Jan 9, 2024 | AMPH | Officer | Form 144 notice | 86,156 | $5.1M | Notice | SEC | |
| Jan 8, 2024 | Jan 8, 2024 | AMPH | Officer | Form 144 notice | 133,644 | $7.9M | Notice | SEC | |
| May 19, 2022 | May 20, 2022 | AMPH | CEO & Chief Scientific Officer | Form 4 sale | 108,776 | $3.7M | 4.9% | Plan not stated | SEC |
| May 17, 2022 | May 18, 2022 | AMPH | CEO & Chief Scientific Officer | Form 4 sale | 118,445 | $4.2M | 5.1% | Plan not stated | SEC |
| Sep 11, 2019 | Sep 12, 2019 | AMPH | COO,Chief Scientist & Chairman | Form 4 sale | 300,000 | $6.2M | 4.1% | Plan not stated | SEC |
| Dec 13, 2018 | Dec 13, 2018 | AMPH | COO,Chief Scientist & Chairman | Form 4 sale | 133,915 | $2.9M | 1.8% | Plan not stated | SEC |
| Dec 11, 2015 | Dec 11, 2015 | AMPH | COO & Chief Scientist | Form 4 sale | 63,300 | $902k | 0.8% | Plan not stated | SEC |
| Jun 9, 2015 | Jun 9, 2015 | AMPH | COO, Chief Scientist, Chairman | Form 4 sale | 193,758 | $3.2M | 17.4% | Plan not stated | SEC |